The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Items 101–200 of 847
Epigenetic Regulators as the Gatekeepers of Hematopoiesis
Rodrigues, C. P., Shvedunova, M., & Akhtar, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.015 · Cited by 99
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
Staudt, D. E., Murray, H. C., McLachlan, T., Alvaro, F., Enjeti, A. K., Verrills, N. M., & Dun, M. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103198 · Cited by 82
The power and potential of integrated diagnostics in acute myeloid leukaemia
Haferlach, T., & Schmidts, I. (2019) · British Journal of Haematology · doi:10.1111/bjh.16360 · Cited by 81
Rowan, A. G., Dillon, R. J., Witkover, A., Melamed, A., Demontis, M.-A., Gillet, N. A., Mun, L. J., Bangham, C. R. M., Cook, L. B., Fields, P. A., et al. (2020) · Blood · doi:10.1182/blood.2019002665 · Cited by 84
Germline risk of clonal haematopoiesis
Silver, A. J., Bick, A. G., & Savona, M. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00356-6 · Cited by 86
Boettcher, S., Wilk, C. M., Singer, J., Beier, F., Burcklen, E., Beisel, C., Ferreira, M. S. V., Gourri, E., Gassner, C., Frey, B. M., et al. (2020) · Blood · doi:10.1182/blood.2019003079 · Cited by 80
Fe3O4@Pt nanozymes combining with CXCR4 antagonists to synergistically treat acute myeloid leukemia
Kong, F., Bai, H., Ma, M., Wang, C., Xu, H., Gu, N., & Zhang, Y. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101106 · Cited by 81
Husby, S., Favero, F., Nielsen, C., Sørensen, B. S., Bæch, J., Grell, K., Hansen, J. W., Rodríguez-González, F. G., Haastrup, E. K., Fischer‐Nielsen, A., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0795-z · Cited by 82
Huang, Y., Chen, C.-W., Sundaramurthy, V., Slabicki, M. M., Hao, D., Watson, C. J., Tovy, A., Reyes, J. M., Dakhova, O., Crovetti, B. R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0560 · Cited by 83
Avogbe, P. H., Manel, A., Vian, E., Durand, G., Forey, N., Voegele, C., Zvereva, M. I., Hosen, M. I., Meziani, S., Tilly, B. D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.004 · Cited by 76
Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age
Zito, A., Davies, M. N., Tsai, P.-C., Roberts, S., Ejarque, R. A., Nardone, S., Bell, J. T., Wong, C. C. Y., & Small, K. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13340-w · Cited by 73
Ferrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 80
Clonal dynamics of haematopoiesis across the human lifespanPreprint
Mitchell, E., Chapman, M. S., Williams, N., Dawson, K. J., Mende, N., Calderbank, E. F., Jung, H., Mitchell, T. J., Coorens, T. H. H., Spencer, D. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.16.456475 · Cited by 74
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer
Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 73
Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals
van Zeventer, I. A., de Graaf, A. O., Wouters, H. J. C. M., van der Reijden, B. A., van der Klauw, M. M., de Witte, T. M., Jonker, M. A., Malcovati, L., Jansen, J. H., & Huls, G. A. (2020) · Blood · doi:10.1182/blood.2019004362 · Cited by 74
Genome Sequencing during a Patient’s Journey through Cancer
Nangalia, J., & Campbell, P. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1910138 · Cited by 66
Self-citationBamopoulos, S. A., Batcha, A. M. N., Jurinović, V., Rothenberg‐Thurley, M., Janke, H., Ksienzyk, B., Philippou‐Massier, J., Graf, A., Krebs, S., Blum, H., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0839-4 · Cited by 77
Synonymous mutations reveal genome-wide levels of positive selection in healthy tissues
Poon, G. Y. P., Watson, C. J., Fisher, D. S., & Blundell, J. R. (2021) · Nature Genetics · doi:10.1038/s41588-021-00957-1 · Cited by 67
Wendorff, A. A., Quinn, S. A., Rashkovan, M., Madubata, C. J., Ambesi‐Impiombato, A., Litzow, M. R., Tallman, M. S., Paietta, E. M., Paganin, M., Basso, G., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1005 · Cited by 72
Clinical Relevance of Clonal Hematopoiesis in the Oldest-Old Population
Rossi, M., Meggendorfer, M., Zampini, M., Tettamanti, M., Riva, E., Travaglino, E., Bersanelli, M., Mandelli, S., Galbussera, A. A., Mosca, E., et al. (2020) · Blood · doi:10.1182/blood.2021011320 · Cited by 73
Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Uddin, M. M., Zhou, Y., Bick, A. G., Burugula, B. B., Jaiswal, S., Desai, P. M., Honigberg, M. C., Love, S.-A. M., Barac, A., Hayden, K. M., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00278-9 · Cited by 73
Fei, D. L., Zhen, T., Durham, B. H., Ferrarone, J. R., Zhang, T., Garrett, L. J., Yoshimi, A., Abdel-Wahab, O. I., Bradley, R. K., Liu, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812669115 · Cited by 72
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182
Juliusson, G., Jädersten, M., Deneberg, S., Lehmann, S., Möllgård, L., Wennström, L., Antunović, P., Cammenga, J., Lorenz, F., Ölander, E., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001335 · Cited by 68
The Genetics and Mechanisms of T-Cell Acute Lymphoblastic LeukemiaPreprint
Gianni, F., Belver, L., & Ferrando, A. A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035246 · Cited by 69
Clonal Hematopoiesis and Its Impact on Human Health
Ahmad, H., Jahn, N., & Jaiswal, S. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112347 · Cited by 66
High efficiency error suppression for accurate detection of low-frequency variants
Wang, T.-T., Abelson, S., Zou, J., Li, T.-T., Zhao, Z., Dick, J., Shlush, L., Pugh, T. J., & Bratman, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz474 · Cited by 61
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
Yura, Y., Sano, S., & Walsh, K. X. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.006 · Cited by 69
Cortés-López, M., Chamely, P., Hawkins, A. G., Stanley, R. F., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C. Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.012 · Cited by 69
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
Terraneo, N., Jacob, F., Dubrovska, A., & Grünberg, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00319 · Cited by 68
Clonal hematopoiesis as a model for premalignant changes during aging
Steensma, D. P., & Ebert, B. L. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.001 · Cited by 65
Clonal hematopoiesis in the inherited bone marrow failure syndromes
Tsai, F. D., & Lindsley, R. C. (2020) · Blood · doi:10.1182/blood.2019000990 · Cited by 69
Alterations to DNMT3A in Hematologic Malignancies
Venugopal, K., Feng, Y., Shabashvili, D. E., & Guryanova, O. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3033 · Cited by 70
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
Zioni, N., Bercovich, A. A., Chapal-Ilani, N., Bacharach, T., Rappoport, N., Solomon, A., Avraham, R., Kopitman, E., Porat, Z., Sacma, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36906-1 · Cited by 67
Clonal hematopoiesis in cancer
Park, S. J., & Bejar, R. L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.02.001 · Cited by 66
Gondek, L. P., & Dezern, A. E. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30211-x · Cited by 67
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
Guermouche, H., Ravalet, N., Gallay, N., Deswarte, C., Foucault, A., Beaud, J., Rault, E., Saindoy, E., Lachot, S., Martignoles, J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001582 · Cited by 65
Clonal Hematopoiesis Before, During, and After Human Spaceflight
Mencia-Trinchant, N., MacKay, M. J., Chin, C. R., Afshinnekoo, E., Foox, J., Meydan, C., Butler, D., Mozsary, C., Vernice, N. A., Darby, C. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108458 · Cited by 62
ASXL1 mutation in clonal hematopoiesis
Fujino, T., & Kitamura, T. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.002 · Cited by 64
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
Benard, B. A., Leak, L. B., Azizi, A., Thomas, D., Gentles, A. J., & Majeti, R. (2021) · Nature Communications · doi:10.1038/s41467-021-27472-5 · Cited by 62
The Clinical Management of Clonal Hematopoiesis
Bolton, K. L., Zehir, A., Ptashkin, R. N., Patel, M. A., Gupta, D., Sidlow, R., Papaemmanuil, E., Berger, M. F., & Levine, R. L. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.11.006 · Cited by 60
Levine, R. L., & Valk, P. J. M. (2019) · Haematologica · doi:10.3324/haematol.2018.205955 · Cited by 60
Acute Myeloid Leukemia: Aging and Epigenetics
Zjablovskaja, P., & Florian, M. C. (2019) · Cancers · doi:10.3390/cancers12010103 · Cited by 61
The evolution of hematopoietic cells under cancer therapy
Pich, O., Cortés‐Bullich, A., Muiños, F., Pratcorona, M., González-Pérez, A., & López-Bigas, N. (2021) · Nature Communications · doi:10.1038/s41467-021-24858-3 · Cited by 60
Boucai, L., Falcone, J., Ukena, J., Coombs, C. C., Zehir, A., Ptashkin, R. N., Berger, M. F., Levine, R. L., & Fagin, J. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00803 · Cited by 57
Clonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 63
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
Arguelles, O. C., Schöffel, A. C., Capo‐Chichi, J., Abdel-Qadir, H. M., Schuh, A. C., Estrada, M. C., Liu, S., Gupta, V. K., Schimmer, A. D., Yee, K. W. L., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.11.008 · Cited by 60
Singh, J., Li, N., Ashrafi, E., Thảo, L. T. P., Curtis, D. J., Wood, E. M., & McQuilten, Z. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013228 · Cited by 60
Appelbaum, L., Cambronero, J., Stevens, J. P., Horng, S., Pollick, K., Silva, G., Haneuse, S., Piatkowski, G., Benhaga, N., Duey, S., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.10.019 · Cited by 55
Clonal hematopoiesis in sickle cell disease
Liggett, L. A., Cato, L. D., Weinstock, J. S., Zhang, Y., Nouraie, M. S., Gladwin, M. T., Garrett, M. E., Ashley‐Koch, A. E., Telen, M. J., Custer, B., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156060 · Cited by 61
Huang, Y., Chen, C.-W. D., Sundaramurthy, V., Slabicki, M. M., Hao, D., Watson, C. J., Tovy, A., Reyes, J. M., Dakhova, O., Crovetti, B. R., et al. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.74923 · Cited by 56
Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
Porta‐Pardo, E., Valencia, A., & Godzik, A. (2020) · FEBS Letters · doi:10.1002/1873-3468.13781 · Cited by 57
West, R. R., Calvo, K. R., Embree, L. J., Wang, W., Tuschong, L. M., Bauer, T. R., Tillo, D., Lack, J., Droll, S. H., Hsu, A. P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005065 · Cited by 56
Wong, W., Bhatt, S. T., Trinkaus, K. M., Pusic, I., Elliott, K., Mahajan, N., Wan, F., Switzer, G. E., Confer, D. L., DiPersio, J. F., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax6249 · Cited by 52
Kennedy, S. R., Zhang, Y., & Risques, R. A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.07.007 · Cited by 59
Bhat, K. S., Byun, S., Alam, A., Ko, M., An, J., & Lim, S. (2022) · Talanta · doi:10.1016/j.talanta.2022.123421 · Cited by 53
Clonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 63
Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality
Hansen, J. W., Pedersen, D. A., Larsen, L. A., Husby, S., Clemmensen, S. B., Hjelmborg, J., Favero, F., Weischenfeldt, J., Christensen, K., & Grønbæk, K. (2019) · Blood · doi:10.1182/blood.2019001793 · Cited by 53
Liu, C., Chang, S., Chen, H., Chen, W.-S., Lin, Y., Lo, L., Hu, Y., Chung, F., Chao, T., Tuan, T., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008518 · Cited by 54
Williams, N., Lee, J., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A. H., Godfrey, A. L., Green, A. R., Campbell, P. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.09.374710 · Cited by 56
Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies
Marshall, C. H., Gondek, L. P., Luo, J., & Antonarakis, E. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0985 · Cited by 54
Prevalence and significance of DDX41 gene variants in the general population
Kovilakam, S. C., Gu, M., Dunn, W. G., Marando, L., Bárcena, C., Nik‐Zainal, S., Mohorianu, I. I., Kar, S. P., Fabre, M. A., Quirós, P. M., et al. (2023) · Blood · doi:10.1182/blood.2023020209 · Cited by 52
ERCC6L2 defines a novel entity within inherited acute myeloid leukemia
Douglas, S. P. M., Siipola, P., Kovanen, P. E., Pyörälä, M., Kakko, S., Savolainen, E., Salmenniemi, U., Orte, K. J., Kytölä, S. I., Pitkänen, E., et al. (2019) · Blood · doi:10.1182/blood-2019-01-896233 · Cited by 55
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
Kim, W. J., Crosse, E. I., Neef, E. D., Etxeberría, I., Sabio, E. Y., Wang, E., Bewersdorf, J. P., Lin, K., Lu, S. X., Belleville, A. E., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.047 · Cited by 52
Soerensen, J. F., Aggerholm, A., Kerndrup, G. B., Hansen, M. H., Ewald, I. K. L., Bill, M., Ebbesen, L. H., Rosenberg, C. A., Hokland, P., Ludvigsen, M., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001157 · Cited by 51
Personalized lab test models to quantify disease potentials in healthy individuals
Cohen, N. M., Schwartzman, O., Jaschek, R., Lifshitz, A., Hoichman, M., Balicer, R. D., Shlush, L. I., Barbash, G., & Tanay, A. (2021) · Nature Medicine · doi:10.1038/s41591-021-01468-6 · Cited by 49
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1
Agarwal, P., Sampson, A. M., Hueneman, K. M., Choi, K., Jakobsen, N. A., Uible, E. E., Ishikawa, C., Yeung, J., Bolanos, L. C., Zhao, X., et al. (2025) · Nature · doi:10.1038/s41586-025-08938-8 · Cited by 56
Advances in cell membrane-coated nanoparticles and their applications for bone therapy
Chen, Y., Zhu, M., Huang, B., Jiang, Y., & Su, J. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213232 · Cited by 49
TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
George, B., Kantarjian, H. M., Baran, N., Krocker, J. D., & Rios, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910782 · Cited by 53
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
Gozdecka, M., Dudek, M., Wen, S., Gu, M., Stopforth, R. J., Rak, J. M., Damaskou, A., Grice, G. L., McLoughlin, M. A., Bond, L., et al. (2025) · Nature · doi:10.1038/s41586-025-08980-6 · Cited by 56
Clonal hematopoiesis, aging, and cardiovascular diseases
Pardali, E., Dimmeler, S., Zeiher, A. M., & Rieger, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.006 · Cited by 50
Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target
Schuermans, A., & Honigberg, M. C. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01148-9 · Cited by 52
Clonal Hematopoiesis and Its Impact on Cardiovascular Disease
Sano, S., Wang, Y., & Walsh, K. X. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0871 · Cited by 50
Delineating the evolutionary dynamics of cancer from theory to reality
Božić, I., & Wu, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0079-6 · Cited by 46
Clonal hematopoiesis and its emerging effects on cellular therapies
Bonin, M. V., Jambor, H. K., Teipel, R., Stölzel, F., Thiede, C., Damm, F., Kroschinsky, F., Schetelig, J., Chavakis, T., & Bornhäuser, M. (2021) · Leukemia · doi:10.1038/s41375-021-01337-8 · Cited by 50
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
Cappelli, L. V., Meggendorfer, M., Baer, C. R., Nadarajah, N., Hütter, S., Jeromin, S., Dicker, F., Kern, W., Haferlach, T., Haferlach, C., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01368-1 · Cited by 50
Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade
Miller, P. G., Gibson, C. J., Mehta, A., Sperling, A. S., Frederick, D. T., Manos, M. P., Miao, B., Hacohen, N., Hodi, F. S., Boland, G. M., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00186 · Cited by 47
Mitochondrial Contributions to Hematopoietic Stem Cell Aging
Morganti, C., & Ito, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011117 · Cited by 50
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Diamond, B. T., Ziccheddu, B., Maclachlan, K. H., Taylor, J., Boyle, E. M., Ossa, J. A., Jahn, J., Affer, M., Totiger, T. M., Coffey, D. G., et al. (2023) · Blood · doi:10.1182/blood.2022018244 · Cited by 47
Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner
Wang, M., Brandt, L. T. L., Wang, X., Russell, H., Mitchell, E., Kamimae-Lanning, A. N., Brown, J. M., Dingler, F. A., Garaycoechea, J. I., Isobe, T., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.035 · Cited by 51
Clonal hematopoiesis: Pre-cancer PLUS
Silver, A. J., & Jaiswal, S. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.003 · Cited by 46
Eskelund, C. W., Husby, S., Favero, F., Klausen, T. W., Rodríguez-González, F. G., Kolstad, A., Pedersen, L. B., Räty, R., Geisler, C. H., Jerkeman, M., et al. (2020) · Blood · doi:10.1182/blood.2019003539 · Cited by 45
What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics
Steensma, D. P., & Bolton, K. L. (2020) · Blood · doi:10.1182/blood.2019004291 · Cited by 45
Peroni, E., Randi, M. L., Rosato, A., & Cagnin, S. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02841-8 · Cited by 51
A brief, but comprehensive, guide to clonal evolution in aplastic anemia
Babushok, D. V. (2018) · Hematology · doi:10.1182/asheducation-2018.1.457 · Cited by 45
Concordance for clonal hematopoiesis is limited in elderly twins
Fabre, M. A., McKerrell, T., Zwiebel, M., Vijayabaskar, M. S., Park, N., Wells, P. M., Rad, R., Deloukas, P., Small, K. S., Steves, C. J., et al. (2019) · Blood · doi:10.1182/blood.2019001807 · Cited by 43
Wilhelmson, A. S., & Porse, B. T. (2020) · British Journal of Haematology · doi:10.1111/bjh.16534 · Cited by 45
Cucchi, D. G. J., Groen, R. W. J., Janssen, J. J. W. M., & Cloos, J. J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100730 · Cited by 45
Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Feusier, J. E., Arunachalam, S., Tashi, T., Baker, M. J., Vansant-Webb, C. H., Ferdig, A., Welm, B. E., Rodríguez-Flores, J. L., Ours, C., Jorde, L. B., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0094 · Cited by 45
Mayerhofer, E., Strecker, C., Becker, H., Georgakis, M. K., Uddin, M. M., Hoffmann, M. M., Nadarajah, N., Meggendorfer, M., Haferlach, T., Rosand, J., et al. (2023) · Stroke · doi:10.1161/strokeaha.122.041416 · Cited by 41
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Marando, L., & Huntly, B. J. P. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00918-7 · Cited by 41
Kiefer, K. C., Cremer, S., Pardali, E., Aßmus, B., Abou‐El‐Ardat, K., Kirschbaum, K., Dorsheimer, L., Rasper, T., Berkowitsch, A., Serve, H. L., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13297 · Cited by 46
Somatic variation in normal tissues: friend or foe of cancer early detection?
Acha‐Sagredo, A., Ganguli, P., & Ciccarelli, F. D. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.156 · Cited by 41
Homan, C. C., Drazer, M. W., Yu, K., Lawrence, D., Feng, J., Arriola‐Martinez, L., Pozsgai, M. J., McNeely, K. E., Ha, T., Venugopal, P., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010045 · Cited by 41
Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy
Kanagal‐Shamanna, R., Beck, D. B., & Calvo, K. R. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-122724 · Cited by 46
Morganti, S., Gibson, C. J., Jin, Q., Santos, K., Patel, A., Wilson, A., Merrill, M. S., Vincuilla, J., Stokes, S., Lipsyc-Sharf, M. D., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01071 · Cited by 41
Mutations in normal tissues—some diagnostic and clinical implications
Fiala, C., & Diamandis, E. P. (2020) · BMC Medicine · doi:10.1186/s12916-020-01763-y · Cited by 42
Clonal hematopoiesis: Molecular and clinical implications
Kusne, Y. N., Xie, Z., & Patnaik, M. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106787 · Cited by 43
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients
Panagiota, V., Kerschbaum, J. F., Penack, O., Stein, C. M., Arends, C. M., Koenecke, C., Strzelecka, P. M., Kloos, A., Wiegand, L., Lasch, A., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000957 · Cited by 44
Stem-Cell Aging and Pathways to Precancer Evolution
Jamieson, C. H. M., & Weissman, I. L. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2304431 · Cited by 39
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
